Coherus Biosciences | CHRS - Текущие обязательства





Текущие обязательства Изменить Дата
AbbVie USD 43.1B 1.46B 2026-09
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Akebia Therapeutics USD 162.35M 1.48M 2026-09
ALKERMES USD 651.93M 10.16M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amarin USD 175.14M 10.94M 2026-09
Amgen USD 23.23B 2.27B 2026-09
Baxter International USD 3.81B 218M 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Coherus Biosciences USD 75.51M 56.82M 2026-06
Eli Lilly USD 47B 745M 2026-09
Fujifilm JPY 1.35T 95.27B 2026-09
Gilead Sciences USD 12B 982M 2026-09
Ironwood Pharmaceuticals USD 34.73M 1.88M 2026-09
Merck USD 28.8B 1.07B 2026-09
Myriad Genetics USD 130.7M 500K 2026-06
Pacira USD 126.1M 4.08M 2026-09
Perrigo USD 1.02B 34.4M 2026-09
Pfizer USD 31.73B 920M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Teva Pharmaceutical Industries USD 15.42B 221M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09
Xencor USD 76.27M 5.6M 2026-09
Zoetis USD 2.68B 621M 2026-09